Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Bays

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Heart Disease and Stroke : a Journal for Primary Care Physicians|November 1, 1992
Drug treatment of dyslipidemias: practical guidelines for the primary care physicianH E Bays, C A Dujovne, A M Lansing
International Journal of Clinical Practice|November 13, 2010
What men should know about metabolic syndrome, adiposopathy and 'sick fat'H E Bays, J M Gonzalez-Campoy, A B Schorr
European Journal of Clinical Nutrition|September 6, 2012
Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trialH E Bays, J L Evans, K C Maki, et al.
International Journal of Clinical Practice|August 21, 2009
Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease?H E Bays, B Laferrère, J Dixon, et al.
International Journal of Clinical Practice|August 7, 2008
Is adiposopathy (sick fat) an endocrine disease?H E Bays, J M González-Campoy, R R Henry, et al.
International Journal of Clinical Practice|June 16, 2012
Rate and risk predictors for development of self-reported type-2 diabetes mellitus over a 5-year period: the SHIELD studyH W Rodbard, H E Bays, J R Gavin, et al.
International Journal of Clinical Practice|April 16, 2008
Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: results from a randomised placebo-controlled clinical trialJ F Paolini, Y B Mitchel, R Reyes, et al.
International Journal of Clinical Practice|January 27, 2009
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemiaD Maccubbin, H E Bays, A G Olsson, et al.
Obesity Pillars|March 3, 2025
Weight and cardiometabolic effects of a novel oral shape-shifting superabsorbent hydrogel capsule: Prespecified and exploratory analysis of the Epitomee capsule RESET studyH E Bays, J D Ard, P M O'Neil, et al.
Clinical Therapeutics|September 18, 2001
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studiesH E Bays, P B Moore, M A Drehobl, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Heart Disease and Stroke : a Journal for Primary Care Physicians|November 1, 1992
Drug treatment of dyslipidemias: practical guidelines for the primary care physicianH E Bays, C A Dujovne, A M Lansing
International Journal of Clinical Practice|November 13, 2010
What men should know about metabolic syndrome, adiposopathy and 'sick fat'H E Bays, J M Gonzalez-Campoy, A B Schorr
European Journal of Clinical Nutrition|September 6, 2012
Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trialH E Bays, J L Evans, K C Maki, et al.
International Journal of Clinical Practice|August 21, 2009
Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease?H E Bays, B Laferrère, J Dixon, et al.
International Journal of Clinical Practice|August 7, 2008
Is adiposopathy (sick fat) an endocrine disease?H E Bays, J M González-Campoy, R R Henry, et al.
International Journal of Clinical Practice|June 16, 2012
Rate and risk predictors for development of self-reported type-2 diabetes mellitus over a 5-year period: the SHIELD studyH W Rodbard, H E Bays, J R Gavin, et al.
International Journal of Clinical Practice|April 16, 2008
Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: results from a randomised placebo-controlled clinical trialJ F Paolini, Y B Mitchel, R Reyes, et al.
International Journal of Clinical Practice|January 27, 2009
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemiaD Maccubbin, H E Bays, A G Olsson, et al.
Obesity Pillars|March 3, 2025
Weight and cardiometabolic effects of a novel oral shape-shifting superabsorbent hydrogel capsule: Prespecified and exploratory analysis of the Epitomee capsule RESET studyH E Bays, J D Ard, P M O'Neil, et al.
Clinical Therapeutics|September 18, 2001
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studiesH E Bays, P B Moore, M A Drehobl, et al.
Pageof 2